Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Recordati SpA

$55m For Akebia As Otsuka Confirms Vadadustat Exit

Japanese firm extricates itself from international deals for oral anemia drug, leaving Akebia potentially needing to find a new partner to progress development and commercialization.

Business Strategies Commercial

Otsuka/Lundbeck Closer To Adding Alzheimer’s Agitation To Rexulti Label

With no currently approved treatment for agitation in Alzheimer’s disease, analysts see a solid revenue opportunity for Rexulti. The companies plan to file a supplemental NDA later this year.

Clinical Trials Business Strategies

Asia Deal Watch: invoX Builds Novel Pipeline Through $161m F-star Acquisition

F-star's novel bispecific technology attracts Sino Biopharma-affiliated acquisition, Shionogi agreement with GARDP brings antibiotic cefiderocol to 135 countries, deal with WinHealth covering Greater China expands Quoin’s licensing of Netherton syndrome candidate to 60 nations, Kyorin and CellGenTech team up in Fabry disease.

Deal Watch Business Strategies

More De-Risking Required Before Pharma Dives Into Psychedelics

One of the best-attended sessions at the BIO meeting in San Diego saw psychedelics specialists weighing up the sector's chances of breaking taboos and getting to market.

Neurology Companies
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
  • Pharmaceuticals
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Bouchara Recordati
    • Dr. F. Frik Ilaç A.S.
    • Opalia Pharma S.A.
    • Orphan Europe
    • Recordati Pharmaceuticals Ltd.
    • Laboratorios Casen Fleet
    • Italchimici S.p.A.
    • Pro Farma AG
    • Recordati S.A. Chemical and Pharmaceutical Company
    • Recordati Rare Diseases Canada Inc.
    • Natural Point S.r.l.
    • Tonipharm S.A.S.
    • FIMEI S.p.A
    • Rossini Investimenti S.p.A
UsernamePublicRestriction

Register